Related Experiment Videos
The expanding indications for clozapine
C R Young1, J G Longhurst, M B Bowers
1Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06504, USA.
Experimental and Clinical Psychopharmacology
|August 1, 1997
Summary
Clozapine is increasingly used beyond treatment-resistant schizophrenia. This review explores its efficacy and risks across various psychiatric and neurologic conditions, suggesting broad therapeutic potential.
Area of Science:
- Pharmacology
- Psychiatry
- Neurology
Background:
- Clozapine is primarily known for treating treatment-resistant schizophrenia.
- Its use is expanding to other clinical indications.
- Understanding its risks and benefits in broader contexts is crucial.
Purpose of the Study:
- To review the literature on clozapine's use for conditions beyond treatment-resistant schizophrenia.
- To critically evaluate the evidence for its efficacy in various disorders.
- To explore the pharmacodynamic basis for its potential therapeutic effects.
Main Methods:
- Literature review of studies on clozapine's application in diverse clinical conditions.
- Reassessment of risks, particularly agranulocytosis.
- Analysis of evidence for efficacy in schizophrenia (treatment-resistant and non-resistant), mood disorders, neurologic conditions, substance abuse, aggression, and childhood schizophrenia.
Main Results:
- Clozapine is being explored for a wider range of indications than previously established.
- Evidence suggests potential efficacy in mood disorders, neurologic conditions, substance abuse, aggression, and childhood schizophrenia.
- The unique pharmacodynamic profile of clozapine is theorized to underpin its broad applicability.
Conclusions:
- Clozapine may be an effective treatment for a wide spectrum of disorders beyond its traditional indication.
- Further research is warranted to fully elucidate its therapeutic potential and optimize its use.
- Risk-benefit assessment remains critical for informed clinical decision-making.